Renalytix AI (GB:RENX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Renalytix AI has announced the successful admission of its Second Tranche Placing Shares for trading on the AIM market of the London Stock Exchange, with trading beginning on July 2, 2024. These shares, totaling 26,815,841, are fully paid and carry the same rights as the existing Ordinary Shares, including dividends and distributions. The company’s total issued share capital remains unchanged at 154,368,191 Ordinary Shares.
For further insights into GB:RENX stock, check out TipRanks’ Stock Analysis page.